https://doi.org/10.4081/ripppo.2020.464
After more than sixty years we are still unclear whether LSD has a place in clinical psychiatry
Submitted: May 18, 2020
Accepted: July 6, 2020
Published: October 1, 2020
Accepted: July 6, 2020
Abstract Views: 814
PDF: 482
HTML: 169
HTML: 169
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor, The use of the psychedelic Lysergic Acid Diethylamide (LSD) has again provoked scientific debate over its efficacy and safety. In the 1950s-1960s LSD was used in psychotherapy for treating depression, anxiety related to terminal cancer, addiction, and pain. (...)
Bonson, K. (1996). Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology, 14, 425-436.
DOI: https://doi.org/10.1016/0893-133X(95)00145-4
Carhart-Harris, R.L., and Goodwin, G.M. (2017). The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42, 2105–2113;
DOI: https://doi.org/10.1038/npp.2017.84
Carhart-Harris, R.L., Bolstridge, M., & Rucker. J., et al. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry, 3(7), 619-27.
DOI: https://doi.org/10.1016/S2215-0366(16)30065-7
Fuentes, J.J., Fonseca, F., Elices, M., Farré., M., & Torrens, M. (2020) Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Front. Psychiatry, 10, 943.
Gasser, P., Kirchner, K., and Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29(1), 57–68.
DOI: https://doi.org/10.1177/0269881114555249
Mithoefer, M.C., Wagner, T.M., Mithoefer, A.T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439-452.
DOI: https://doi.org/10.1177/0269881110378371
Mithoefer, M.C., Mithoefer, A.T., Feduccia. L., et al. (2018). MDMA-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry, 55(6), 486-497.
DOI: https://doi.org/10.1016/S2215-0366(18)30135-4
Nutt, D. (2019). Psychedelic drugs—a new era in psychiatry? Dialogues in Clinical Neuroscience, 21(2), 139-147.
DOI: https://doi.org/10.31887/DCNS.2019.21.2/dnutt
Tupper, K.W., Wood, E., Yensen, R., & Johnson, M.W. (2015). Psychedelic medicine: a re-emerging therapeutic paradigm. CMAJ, 187(14), 1054-1059.
DOI: https://doi.org/10.1503/cmaj.141124
Ungerleider, J.T., & Adrysiak, T. (1981). Therapeutic uses of the drugs of abuse. Annals of the New York Academy of Sciences, 362, 173-180.
DOI: https://doi.org/10.1111/j.1749-6632.1981.tb12805.x
How to Cite
Saniotis, A. (2020). After more than sixty years we are still unclear whether LSD has a place in clinical psychiatry. Research in Psychotherapy: Psychopathology, Process and Outcome, 23(2). https://doi.org/10.4081/ripppo.2020.464
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
